Targeted protein degradation (TPD) is getting a lot of attention as a promising modality to treat a variety of diseases from ...

New research from the University of Dundee shows potential breakthrough for hard to treat cancers. Experts from the ...

KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim ...

Lindorff-Larsen describes himself as, “a protein chemist who happens to use computers.” Lindorff-Larsen wanted to develop an efficient approach to characterize all the conformational ensembles of ...

Discover C4 Therapeutics' groundbreaking patent for BRD9-degrading compounds, targeting disorders like synovial sarcoma. Explore innovative treatments for better outcomes!

Researchers show how stop codon readthrough plays a key role in the cell cycle, with implications for cancer cell ...

Protein And Fiber Kinetics. . Expanding The Boundaries Of Feed Formulation. By Fiona Tansil. Protein and fibre are two of the key nutrients that swine n ...

The life-saving use of messenger RNA (mRNA) in COVID-19 vaccines was a public example of the potential of mRNA-based ...

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

Imagine a world where Alzheimer's disease could be effectively treated, not just managed. We might be one step closer to that ...

A love of food -- and, well, cheese -- has landed German fermentation startup Formo's co-founder Roman Plewka and its team a ...